Literature DB >> 10590177

Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells.

C L Delaney1, H L Cheng, E L Feldman.   

Abstract

Both neurons and glia succumb to programmed cell death (PCD) when deprived of growth factors at critical periods in development or following injury. Insulin-like growth factor-I (IGF-I) prevents apoptosis in neurons in vitro. To investigate whether IGF-I can protect Schwann cells (SC) from apoptosis, SC were harvested from postnatal day 3 rats and maintained in serum-containing media until confluency. When cells were switched to serum-free defined media (DM) for 12-72 h, they underwent PCD. Addition of insulin or IGF-I prevented apoptosis. Bisbenzamide staining revealed nuclear condensation and formation of apoptotic bodies in SC grown in DM alone, but SC grown in DM plus IGF-I had normal nuclear morphology. The phosphatidylinositol 3-kinase (PI 3-K) inhibitor LY294002 blocked IGF-I-mediated protection. Caspase-3 activity was rapidly activated upon serum withdrawal in SC, and the caspase inhibitor BAF blocked apoptosis. These results suggest that IGF-I rescues SC from apoptosis via PI 3-K signaling which is upstream from caspase activation. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590177     DOI: 10.1002/(sici)1097-4695(199912)41:4<540::aid-neu9>3.0.co;2-p

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  15 in total

Review 1.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

2.  Involvement of IGF-2, IGF-1R, IGF-2R and PTEN in development of human tooth germ - an immunohistochemical study.

Authors:  Darko Kero; Livia Cigic; Ivana Medvedec Mikic; Tea Galic; Mladen Cubela; Katarina Vukojevic; Mirna Saraga-Babic
Journal:  Organogenesis       Date:  2016-06-21       Impact factor: 2.500

3.  Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Authors:  Dario I Carrasco; Ben A Bahr; Kevin L Seburn; Martin J Pinter
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

4.  Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity.

Authors:  P Maurel; J L Salzer
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

5.  Apoptosis contributes to amphotericin B-induced nephrotoxicity.

Authors:  D E Varlam; M M Siddiq; L A Parton; H Rüssmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 6.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

7.  Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

Authors:  Bhumsoo Kim; Cynthia M van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

8.  MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway.

Authors:  Sharmila Chattopadhyay; Veronica I Shubayev
Journal:  Glia       Date:  2009-09       Impact factor: 7.452

9.  Insulin-like growth factor receptor 1b is required for zebrafish primordial germ cell migration and survival.

Authors:  Peter J Schlueter; Xianpeng Sang; Cunming Duan; Antony W Wood
Journal:  Dev Biol       Date:  2007-02-21       Impact factor: 3.582

10.  Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits following Traumatic Brain Injury in Mice.

Authors:  Sindhu K Madathil; Shaun W Carlson; Jennifer M Brelsfoard; Ping Ye; A Joseph D'Ercole; Kathryn E Saatman
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.